-
Cost of non-persistence with oral bisphosphonates in post-menopausal osteopor...
International audience -
Bisphosphonates and bone diseases: past, present and future.
International audience -
Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of o...
International audience -
Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell ...
International audience -
Farnesyl diphosphate synthase is involved in the resistance to zoledronic aci...
International audience -
Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T ce...
International audience -
Sensitization of ovarian carcinoma cells with zoledronate restores the cytoto...
International audience -
PTH-independent regulation of blood calcium concentration by the calcium-sens...
International audience -
Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the be...
International audience -
Zoledronic acid treatment impairs protein geranyl-geranylation for biological...
BACKGROUND: Nitrogen-containing bisphosphonates (N-BPs) have been designed to inhibit osteoclast-mediated bone resorption. However, it is now accepted that part of... -
[Therapeutic innovation in osteoporosis (antisclerostin antibody and denosuma...
International audience
